Harry Kleanthous
Corporate Officer/Principal at SK BIOSCIENCE CO.,LTD.
Harry Kleanthous active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SK BIOSCIENCE CO.,LTD. | Corporate Officer/Principal | 2022-10-20 | - |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - | - |
Career history of Harry Kleanthous
Training of Harry Kleanthous
| University of London | Doctorate Degree |
Statistics
International
| United Kingdom | 3 |
| South Korea | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SK BIOSCIENCE CO.,LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
- Stock Market
- Insiders
- Harry Kleanthous
- Experience
